Related Experiment Videos
A third case of hemoglobin Memphis-sickle cell disease. Whole blood viscosity used as a screening test
The American Journal of Medicine
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Divergent Cardiac and Renal Outcomes by Systolic Blood Pressure in HFrEF.
The American journal of medicine·2026
Microplastics and Nanoplastics as a Novel Cardiovascular Risk Factor: A Narrative Review.
The American journal of medicine·2026
The Digital Incidentaloma Appreciating and Managing the Hazards of Continuous Digital Monitoring.
The American journal of medicine·2026
Trends in risk of subsequent fracture and post-fracture treatment among post-menopausal US women.
The American journal of medicine·2026
Cardiac Deceleration Capacity Refines Sudden Cardiac Death Risk Stratification in Patients with Hypertrophic Cardiomyopathy for Primary Prevention.
The American journal of medicine·2026
Herpes Zoster as a Trigger of Cardiovascular Events: A Systematic Review of Epidemiological Evidence and Pathophysiological Mechanisms.
The American journal of medicine·2026
Persistent Immune Thrombocytopenia as a Post-Acute Sequelae of COVID-19: A Case Report.
Public health challenges·2026
Hyperacute Graft-Versus-Host Disease.
Bone marrow transplantation·2026